This is the authors' abstract. We don't add key points for this paper.
To the Editors: INTRODUCTION In 2010, pre-exposure prophylaxis (PrEP) became a promising option for HIV prevention. In the iPrEx study, daily oral emtricitabine/tenofovir disoproxil fumarate reduced HIV acquisition by 44% among 2499 men and transgender women who have sex with men and 92% among those with detectable drug levels.1 Although PrEP uptake has been slowly increasing since FDA approval in 2012,2 global scale-up is needed for PrEP to have maximal impact on the HIV epidemic.3 The Health Resources and Services Administration defines telehealth as “the use of electronic information and telecommunications technologies to support and promote long-distance clinical health care, patient and professional health-related education, public health, and health administration.” Telehealth is increasingly being used across the spectrum of clinical medicine. HIV-related examples include training and support of nonspecialists in Project Extension for Community Healthcare Outcomes (ECHO),4 patient consultation,5 videoconferencing for partner services,6 and telephone-administered psychotherapy for HIV-positive persons with depression.7 Telehealth approaches are supported by the Infectious Diseases Society of America8 because they can expand the reach of specialty expertise into rural and remote regions and into populations who might not otherwise access care because of physical barriers or stigma. In 2013, we established a PrEP clinic at Gay City, a Seattle community-based organization that has provided HIV testing and prevention services for over a decade. The once-weekly clinic, started as a pilot research project,9 has become a safety net clinic designed to identify at-risk persons without insurance or primary care providers (PCPs), initiate PrEP if appropriate, and facilitate connections with community PCPs. Because Washington State law requires prescribers to establish a patient–provider relationship defined as, at minimum, a single face-to-face visit, we recently added videoconference appointments when the physician was not physically present. This article describes our preliminary experience using a telehealth approach to prescribe PrEP. METHODS Population English- and Spanish-speaking men and transgender persons reporting sex with men were scheduled for appointments if they reported the following in the previous year: condomless anal sex with a person who was HIV-positive or of unknown serostatus, bacterial sexually transmitted infection, methamphetamine use, or ≥10 partners for oral or anal sex.10 Participants were referred through telephone and email inquiries, other community-based organizations, or following HIV testing appointments. Procedures The Gay City Wellness Center is open from 03:00–08:00 pm Monday to Friday and 12:30–05:00 pm on Saturdays, and initial in-person clinic visits were scheduled on Tuesday afternoons from 03:00–05:30 pm. Clients who could not attend a Tuesday appointment or who were not willing or able to wait until the next open Tuesday slot were offered telemedicine appointments. Most telemedicine appointments occurred on Friday afternoons, but the day and time were negotiable as long as the prescribing provider, Gay City staff member, and room were available. Visits were conducted by 2 HIV counselors who had received training in PrEP-related topics including efficacy, medication adherence, side effects, drug resistance, HIV testing, and acute infection. For initial visits, the physician was present in-person or through interactive videoconference using a secure, HIPAA-compliant platform (Zoom, San Jose, CA). Computers were connected through secure Ethernet connections at Gay City and the physician's office or a password-protected wireless connection at the physician's home. Venipuncture specimens for creatinine, fourth generation HIV antigen–antibody, hepatitis B surface antigen, and rapid plasma reagin testing were collected by the HIV counselor, and pharyngeal and rectal specimens for chlamydia and gonorrhea testing were self-collected. Laboratory evaluations were provided at no cost to participants. Results were reviewed within 1 week, and, if the participant had no symptoms of acute HIV infection, PrEP was prescribed through a commercial pharmacy. The HIV counselors assisted with health care insurance registration or medication assistance paperwork, as needed. Demographic characteristics, insurance status, and HIV-risk behavior were self-reported to Gay City's computer intake and the PrEP clinic eligibility questionnaire. Follow-up appointments were conducted independently by a counselor 1 and 3 months after PrEP initiation to assess side effects, monitor and promote medication adherence, reevaluate HIV status, and connect participants to PCPs. Adherence was self-reported as number of missed doses in the previous week and month. Participants seen through videoconferencing were later asked to complete an anonymous 2-item, online survey to assess program acceptability. Data Analysis Descriptive analyses provided further context and comparison with other participants seen during the same timeframe. Statistical analyses, including χ2 and Fisher exact tests, tests of proportions, and Wilcoxon rank-sum, were performed using Stata13 (StataCorp LP, College Station, TX). This project was considered clinical care and exempt from human subjects research regulations. RESULTS From July 2016 to March 2017, 48 persons seen for initial appointments elected to pursue PrEP; videoconferencing was used for 10 (20.8%) participants and occurred without technical difficulties. Demographics and baseline characteristics of participants are shown (Table 1). There were no significant differences in baseline measures between groups.TABLE 1.: Demographic and Other Baseline Characteristics of Clinic Participants Evaluated July 1, 2016, to March 31, 2017Participants exited the program or were lost at all stages of follow-up. Eleven (23%) of 48 participants were never prescribed PrEP, usually because of incomplete applications for insurance or medication assistance programs. Nine (24%) of the remaining 37 were not seen for the 1-month visit; 4 had insurance issues, 3 were lost to follow-up, and 2 were linked to PCPs. Twenty-two participants were seen for 3-month visits, including 2 participants who had not been seen for a 1-month visit; of the remaining 8 (27%), 4 were lost to follow-up, 2 had not yet scheduled appointments, and 2 were linked to PCPs. To date, 13 additional participants have been confirmed as linked to PCPs. All observed participants remained HIV-negative during follow-up. Compared with standard participants, there were no significant differences in proportions of telehealth participants prescribed PrEP (70% vs. 79%), who attended the first follow-up visit (83% vs. 85%), or adherence at 1 month {median [interquartile range (IQR)] missed doses last month 2 (2–2) vs. 1 (0–3)}. However, only 2 telehealth participants (40% of those not yet connected to a PCP) attended the 3-month visit, compared with 20 (87%) of 23 standard patients (P = 0.05). These 2 reported 10 and 14 missed doses in the previous month, compared with a median of 2 (IQR 0–2) for standard participants. Three telehealth participants completed the survey. All reported that it was very acceptable to see the PrEP doctor using videoconferencing, and they would be very (n = 2) or somewhat (n = 1) likely to recommend a telemedicine visit for PrEP to other people. DISCUSSION This program, among the first of its kind, shows preliminary evidence of the feasibility and acceptability of a telehealth approach to PrEP prescribing that promotes HIV counselors as PrEP experts. This model has several advantages, including the flexibility it provides to the specialist and the transition of time and effort to less-expensive staff who are content experts in HIV and sexual health. Telehealth participants in our project had similar baseline characteristics compared with other participants, but they were significantly less likely to return for their 3-month follow-up. Although conceivable this was due to the physical absence of the physician at the initial visit, it is more likely associated with participant factors that led to the client choosing to be seen on an alternate day. Losses to follow-up are frequently seen throughout the PrEP care continuum,11 including failures to complete medication assistance paperwork, pick up initial prescriptions, refill medications, or follow-up for clinical monitoring. Work is needed to develop strategies to promote PrEP adherence and persistence among persons at highest risk of HIV acquisition and identify individuals most likely to benefit from those strategies. Persons who self-select into telehealth appointments in our delivery model may require such support. The greatest limitation of this report is the small number of participants to date, which limits our ability to make definitive conclusions about a telemedicine approach to PrEP prescribing. Our results may not be generalizable to all populations, and there may be some (eg, based on age or culture) for whom telehealth is less acceptable. Work is needed to understand the acceptability and impact of telehealth in other risk groups. State laws around telehealth prescribing are varied and changing.12 Direct-to-consumer provision of care has previously been limited because providers were unable to bill insurance. In 2015, the Washington State legislature passed a law (SB 5175/HB 1403) requiring reimbursement of telehealth services under certain conditions. For-profit companies such as Nurx, which provides birth control and PrEP in a few U.S. jurisdictions, have bypassed insurance with direct pay. Currently, other options to increase PrEP access include expansion of STD clinic cohorts,13 the cultivation of PrEP specialists and PCP champions, pharmacy-based PrEP clinics,14 and referrals to these access points from community organizations and mHealth tools such as the Healthmindr app.15 Our project adds a novel method for PrEP expansion, potentially replicable in domestic and international organizations, that uses HIV counselors prominently and a telehealth approach to add flexibility.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Stekler et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: